ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts
Earnings Call

Laurus Labs Earnings Call: Key Takeaways

Laurus Labs delivered strong Q4 FY26 results with 23% annual revenue growth and significant EBITDA margin expansion to 26.8%, driven by a transforming CDMO business and generic portfolio ramp-up.

Laurus Labs Ltd NSE: LAURUSLABS Alert sent
Why this was an Alfa AlertNot a filter event. Performance was robust but management indicated results were largely along expectations and in line with broader outlook.
Highlights
Revenue growth23% YoY for full year FY26.
MarginsGross margin healthy at 60%; EBITDA reached 29% in Q4.
Order bookPretty much in place for next year.
Demand visibilityStrong momentum in CDMO and non-ARV generics.
Management confidenceHigh; confident in maintaining or improving EBITDA margins in FY27.

Growth

FY26 Revenue grew 23% to ₹6,813 Cr; PAT surged 148% to ₹889 Cr; EBITDA margins expanded 6.7% to 26.8%.

Outlook

Guided ₹3,000 Cr capex over next 2 years; CDMO targeted to be 50% of revenue by FY30.

Risks

Geopolitical disruptions affecting raw material availability/logistics; solvent price volatility; increased debt for capex.

Source

Earnings Call filed with NSE, NSE: LAURUSLABS. Summary written with AI assistance from the document.

Read the document ↗

Laurus Labs Ltd: key numbers

Share price
₹2,412.50
Market cap
₹1,30,350 Cr
Revenue (annual)
₹6,813 Cr
Net profit (annual)
₹888.8 Cr
P/E (TTM)
97.3×Sector 43.8×
Promoter holding
27.47%+0.00% QoQ
FII holding
30.84%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Laurus Labs Ltd

All →